VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HSIC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HSICHenry Schein, Inc.
$84.29$9.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHSICFinancials

Henry Schein, Inc. (HSIC) Financials

30Y historyFree accessUpdated daily

Revenue growth remains stable at 6.3% as of 2026Q1, though operating margins remain narrow, fluctuating between 2.0% and 6.5% over the last ten quarters.

HSIC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue13.38B13.18B12.67B12.34B12.65B12.4B10.12B9.99B13.2B12.46B11.57B10.63B10.37B9.56B8.94B8.53B7.53B6.54B6.39B5.92B5.15B4.64B4.06B3.35B2.83B2.56B2.38B2.29B1.92B1.52B830M
Revenue Growth %5.64%4.03%2.71%-2.44%1.98%22.55%1.34%-24.36%5.94%7.69%8.86%2.49%8.48%6.94%4.8%13.33%15.12%2.24%8.02%14.89%11.16%14.18%21.06%18.72%10.43%7.41%4.2%18.94%26.59%82.9%34.7%
Cost of Goods Sold9.41B9.34B8.91B8.69B9B8.73B7.3B6.89B6.51B9.06B8.35B7.62B7.46B6.9B6.43B6.11B5.35B4.63B4.51B4.2B3.58B3.32B2.84B2.43B2.03B1.86B1.7B1.56B1.3B1.05B576.8M
COGS % of Revenue-70.86%70.29%70.41%71.15%70.39%72.19%69.05%49.29%72.72%72.12%71.66%71.93%72.22%71.95%71.65%71.13%70.76%70.46%70.98%69.4%71.59%70.05%72.35%71.86%72.66%71.38%68.21%67.64%69.36%69.49%
Gross Profit3.97B3.84B3.77B3.65B3.65B3.67B2.81B3.09B2.91B3.4B3.23B3.01B2.91B2.66B2.51B2.42B2.17B1.91B1.87B1.72B1.47B1.32B1.05B927.19M794.9M699.32M681.66M726.7M621.8M465.2M253.2M
Gross Margin %29.69%29.14%29.71%29.59%28.85%29.61%27.81%30.95%22.05%27.28%27.88%28.34%28.07%27.78%28.05%28.35%28.87%29.24%29.31%29.02%28.56%28.41%25.97%27.65%28.14%27.34%28.62%31.79%32.36%30.64%30.51%
Gross Profit Growth %-2.05%3.12%0.05%-0.63%30.48%-8.95%6.19%-14.37%5.35%7.11%3.47%9.61%5.92%3.7%11.26%13.67%2.01%9.08%16.73%11.77%24.89%13.73%16.64%13.67%2.59%-6.2%16.87%33.66%83.73%28.79%
Operating Expenses3.23B3.08B3.04B2.94B2.71B2.82B2.25B2.36B2.22B2.53B2.41B2.24B2.2B1.98B1.87B1.84B1.64B1.45B1.43B1.33B1.17B1.05B831.51M693.48M598.63M551.57M554.05M607.4M525.6M402.8M223.5M
OpEx % of Revenue-23.39%23.96%23.8%21.44%22.72%22.2%23.61%16.79%20.34%20.82%21.1%21.18%20.7%20.95%21.52%21.76%22.17%22.39%22.5%22.66%22.73%20.48%20.68%21.19%21.56%23.26%26.57%27.35%26.53%26.93%
Selling, General & Admin3.15B3.08B3.04B2.94B2.71B2.82B2.25B2.36B2.22B2.53B2.41B2.24B2.2B1.98B1.87B1.84B1.64B1.45B1.43B1.33B1.17B1.05B831.51M693.48M598.63M551.57M520.29M579.1M505.6M388.4M215.6M
SG&A % of Revenue-23.39%23.96%23.8%21.44%22.72%22.2%23.61%16.79%20.34%20.82%21.1%21.18%20.7%20.95%21.52%21.76%22.17%22.39%22.5%22.66%22.73%20.48%20.68%21.19%21.56%21.84%25.34%26.31%25.58%25.98%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses1000K000000000000000000000000033.76M28.3M20M14.4M7.9M
Operating Income749M758M729M714M938M854.81M567.4M732.97M693.47M864.69M817.47M768.9M715.14M677.05M634.15M582.15M535.86M462.22M442.53M386.26M304.13M263.14M222.95M233.72M197M147.75M127.61M119.3M96.2M62.4M29.7M
Operating Margin %5.6%5.75%5.75%5.79%7.42%6.89%5.61%7.34%5.25%6.94%7.06%7.23%6.9%7.08%7.09%6.82%7.12%7.07%6.92%6.52%5.9%5.68%5.49%6.97%6.97%5.78%5.36%5.22%5.01%4.11%3.58%
Operating Income Growth %-3.98%2.1%-23.88%9.73%50.65%-22.59%5.69%-19.8%5.78%6.32%7.52%5.63%6.77%8.93%8.64%15.93%4.45%14.57%27%15.58%18.03%-4.61%18.64%33.34%15.78%6.97%24.01%54.17%110.1%3070%
EBITDA1.05B1.07B1.03B962M1.15B1.06B752.93M917.91M837.1M1.06B987.25M928.03M867.38M805.09M759.48M698.04M637.07M543.71M520.65M460.19M369.06M323.48M274.28M270.56M225.28M183.39M161.38M147.6M116.2M76.8M37.6M
EBITDA Margin %7.88%8.11%8.1%7.8%9.09%8.58%7.44%9.19%6.34%8.49%8.53%8.73%8.36%8.42%8.5%8.18%8.46%8.32%8.14%7.77%7.16%6.98%6.76%8.07%7.97%7.17%6.78%6.46%6.05%5.06%4.53%
EBITDA Growth %-1.5%4.19%6.65%-16.35%8.05%41.36%-17.97%9.65%-20.86%7.14%6.38%6.99%7.74%6.01%8.8%9.57%17.17%4.43%13.14%24.69%14.09%17.94%1.37%20.1%22.84%13.64%9.33%27.02%51.3%104.26%652%
D&A (Non-Cash Add-back)305M311M297M248M212M209.53M185.54M184.94M143.63M193.07M169.78M159.13M152.24M128.03M125.32M115.9M101.21M81.49M78.13M73.94M64.93M60.34M51.33M36.84M28.27M35.64M33.76M28.3M20M14.4M7.9M
EBIT697M695M644M629M765M858.15M541.27M731.1M612.85M876.5M787.73M746.77M733.37M692.23M635.09M599.68M535.99M476.29M430.05M407.42M322.56M272.11M216.22M232.3M197M147.75M127.61M119.19M96.2M62.6M43.1M
Net Interest Income-120M-117M-107M-70M-27M-21.15M-31.54M-35.03M-60.52M-36.1M-18.62M-13.07M-10.4M-14.69M-17.51M-14.78M-19.86M-13.63M-18.25M-8.65M-11.25M-18.19M-11.49M-1.46M0000000
Interest Income34M33M24M17M17M6.45M9.84M15.76M15.49M17.55M13.28M12.94M13.65M12.85M13.39M15.59M14.1M9.94M16.36M16.53M16.38M7.32M6.11M8.75M0000000
Interest Expense154M150M131M87M44M27.6M41.38M50.79M76.02M53.65M31.89M26.01M24.06M27.54M30.9M30.38M33.96M23.57M34.6M25.18M27.63M25.51M17.6M10.21M6.1M8.6M53.54M49.1M107M86.7M0
Other Income/Expense-202M-213M-203M-158M-202M-4.25M-55.16M-34.76M-135.6M-42.9M-43.11M-34.09M5.9M-2.17M-22.91M2.72M-23.66M-4.26M-42.04M-4.09M-8.37M-15.71M-24.32M-10.4M-6.57M-7.4M-34.71M-33.29M-59.54M-47.1M17.6M
Pretax Income547M545M526M556M736M850.56M512.24M698.21M557.87M821.8M774.35M734.82M721.05M674.89M611.25M584.87M512.2M457.96M400.49M382.17M295.77M247.43M198.63M225.78M188.5M140.35M92.9M85.9M36.6M16.5M30.6M
Pretax Margin %4.09%4.13%4.15%4.51%5.82%6.86%5.06%6.99%4.23%6.59%6.69%6.91%6.95%7.06%6.84%6.86%6.8%7%6.26%6.46%5.74%5.34%4.89%6.73%6.67%5.49%3.9%3.76%1.9%1.09%3.69%
Income Tax129M126M128M120M170M197.35M95.37M159.51M107.43M362.51M217.96M211.39M215.61M190.89M187.86M180.21M160.07M127.52M131.21M129.76M104.93M90.46M73.51M84.38M70.51M51.93M36.15M35.6M20.3M17.5M11.3M
Effective Tax Rate %23.58%23.12%24.33%21.58%23.1%23.2%18.62%22.85%19.26%44.11%28.15%28.77%29.9%28.28%30.73%30.81%31.25%27.85%32.76%33.95%35.48%36.56%37.01%37.37%37.41%37%38.91%41.44%55.46%106.06%36.93%
Net Income395M398M390M416M538M623.91M402.22M507.96M535.88M406.3M506.78M479.06M466.08M444.09M388.08M367.66M325.79M308.64M247.36M234.97M182.74M139.76M128.18M137.51M117.99M87.37M56.75M50.3M16.3M-1M19.3M
Net Margin %2.95%3.02%3.08%3.37%4.25%5.03%3.97%5.09%4.06%3.26%4.38%4.51%4.49%4.64%4.34%4.31%4.33%4.72%3.87%3.97%3.55%3.01%3.16%4.1%4.18%3.42%2.38%2.2%0.85%-0.07%2.33%
Net Income Growth %-2.95%2.05%-6.25%-22.68%-13.77%55.12%-20.82%-5.21%31.89%-19.83%5.79%2.79%4.95%14.43%5.55%12.85%5.56%24.77%5.27%28.58%30.76%9.03%-6.78%16.55%35.04%53.96%12.82%208.59%1730%-105.18%289.22%
Net Income (Continuing)418M419M398M436M566M653.21M416.87M538.69M450.44M459.29M556.39M523.43M505.44M484M423.39M404.66M352.13M330.44M269.28M252.41M190.83M156.97M125.12M138.07M117.99M87.37M56.75M50.31M16.33M-2.2M28.7M
Discontinued Operations000000986K-5.96M105.16M00000000200K000-11.25M2.85M00000000
Minority Interest1.56B1.55B1.44B1.5B1.23B1.25B963.91M919.35M892.61M845.05M615.37M544.75M567.38M500.34M437.45M403.45M305.47M178.6M262K35.92M21.75M12.35M12.44M11.53M6.75M6.79M8M7.9M5.9M2.2M5.3M
EPS (Diluted)3.403.273.053.163.914.452.803.403.492.573.122.852.722.532.161.991.751.701.361.291.010.860.720.770.660.250.170.040.01-0.000.02
EPS Growth %3.44%7.21%-3.48%-19.18%-12.13%58.93%-17.65%-2.58%35.8%-17.63%9.47%4.78%7.51%17.13%8.54%13.71%2.94%25%5.43%27.72%17.44%19.44%-6.49%16.67%164%47.06%323.94%208.46%--105.19%-
EPS (Basic)-3.293.073.183.954.512.823.443.512.593.162.892.772.582.222.041.811.741.391.331.040.870.740.790.670.260.170.040.01-0.000.02
Diluted Shares Outstanding116.06M121.72M127.78M131.75M137.76M141.77M143.4M149.26M153.71M158.21M162.38M168.25M171.48M175.24M179.65M185.24M186.54M181.11M182.44M182.33M179.64M176.98M178.92M179.46M179.3M348.36M340.99M1.25B1.25B1.25B1.25B
Basic Shares Outstanding114.94M120.81M126.79M130.62M136.06M140.09M142.5M147.82M152.66M156.79M160.41M165.69M168.53M171.85M175M180.24M180.19M177.74M178.16M177.12M175.9M174.01M174.51M174.78M174.96M338.93M334.28M1.25B1.25B1.25B1.25B
Dividend Payout Ratio---------------------------292.05%12.27%--

Key Metrics

Growth RegimeStable
ProfitabilityModerate
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Margin compression from DSOs

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Shows Resilient Stability

According to the most recent quarterly filings, Henry Schein achieved a 6.3% revenue growth rate in 2026Q1, maintaining a consistent trajectory that suggests the company is successfully navigating the post-pandemic normalization of demand while leveraging its core dental and medical distribution segments to drive steady top-line expansion.

The company's ability to maintain mid-single-digit growth despite broader macroeconomic headwinds suggests that its non-elective consumable base provides a reliable floor for performance. Investors should monitor whether this growth is increasingly driven by high-margin software services or if it remains tethered to the more cyclical and lower-margin equipment distribution business.

Gross Margin Expansion Warrants Scrutiny

As reported in financial statements, Henry Schein's gross margin reached 31.8% in 2026Q1, representing a notable improvement from the 28.7% observed in 2023Q4, which may indicate a favorable shift in product mix toward higher-margin technology services or more effective procurement strategies within the distribution network.

While this expansion is encouraging, it remains unclear if these gains are sustainable or merely a result of temporary vendor rebate timing. The structural reliance on low-margin distribution suggests that any reversal in this trend could quickly impact the company's ability to maintain its current profitability profile.

Operating Leverage Remains Constrained Historically

Based on the provided income statement data, Henry Schein's operating margin has fluctuated between 2.0% and 6.5% over the last ten quarters, suggesting that the company struggles to achieve significant operating leverage as SG&A expenses often scale in tandem with gross profit growth across the distribution segments.

The persistent difficulty in expanding operating margins implies that the company's cost structure is heavily weighted toward variable logistics and administrative overhead. This lack of scalability may indicate that the integration of recent acquisitions is not yet yielding the expected operational efficiencies required to drive bottom-line growth.

Consolidation Risks Threaten Pricing Power

Data from recent periods indicates that the rise of Dental Service Organizations may challenge Henry Schein's historical pricing power, as these larger entities possess greater leverage to negotiate lower distribution margins, potentially offsetting the gains achieved through the company's proprietary software and value-added service offerings.

Short-term investors should be wary of the potential for margin compression if the shift toward consolidated purchasing continues to accelerate. The company's reliance on fragmented solo practitioners has historically been a key defensive moat, and the erosion of this customer base could fundamentally alter the long-term earnings narrative.

HSIC — Frequently Asked Questions

Quick answers to the most common questions about buying HSIC stock.

What was Henry Schein, Inc.'s (HSIC) revenue in 2025?

For fiscal year 2025, Henry Schein, Inc. (HSIC) reported total revenue of $13.18B. This represents a 1488.4% increase compared to $830.0M in 1996.

Is Henry Schein, Inc. (HSIC) profitable?

Henry Schein, Inc. (HSIC) is profitable, generating $398.0M in net income for the fiscal year ending 2025 with a net profit margin of 3.0%.

What is Henry Schein, Inc.'s operating profit margin?

Henry Schein, Inc. (HSIC) reported an operating income of $758.0M, resulting in an operating profit margin of 5.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Henry Schein, Inc.'s gross profit and gross margin?

Henry Schein, Inc. (HSIC) generated $3.84B in gross profit for the year, representing a gross profit margin of 29.1%. This demonstrates the company's core pricing power and production efficiency.